Home › Myasthenia Gravis › Arizona
Myasthenia Gravis clinical trials in Arizona
7 studies for Myasthenia Gravis are looking for participants at sites in Arizona.
Cities in Arizona
Study to Assess the Efficacy and Safety of IMVT-1402 in Participants With Mild to Severe Generalized Myasthenia Gravis
- Site Number - 1017, Phoenix
- Site Number - 1025, Scottsdale
- Site Number - 1042, Tucson
RecruitingPhase 3
Ages 18 to 80 · All sexes · Updated Nov 13, 2026 · NCT07039916A Study to Evaluate The Long-Term Safety And Efficacy of Rozanolixizumab in Adult Participants With Ocular Myasthenia Gravis
- Mg0039 10104, Scottsdale
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Nov 6, 2026 · NCT07465289A Study to Evaluate the Efficacy and Safety of Rozanolixizumab in Adult Participants With Ocular Myasthenia Gravis
- Mg0038 10104, Scottsdale
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Nov 6, 2026 · NCT07463521A Study of Nipocalimab Administered to Adults With Generalized Myasthenia Gravis
- Neuromuscular Research Center and Clinic, Paradise Valley
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Nov 5, 2026 · NCT04951622A Study of Nipocalimab in Children Aged 2 to Less Than 18 Years With Generalized Myasthenia Gravis
- Phoenix Children's Hospital, Phoenix
RecruitingPhase 2/3
Ages 2 to 17 · All sexes · Updated Nov 4, 2026 · NCT05265273Efficacy and Safety of a New Formulation of Oral Cladribine Compared With Placebo in Participants With Generalized Myasthenia Gravis (MyClad)
- Arizona Neuroscience Research, LLC, Phoenix
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Oct 21, 2026 · NCT06463587Registry of Participants With Generalized Myasthenia Gravis Treated With Alexion C5 Inhibition Therapies (C5ITs)
- Clinical Trial Site, Scottsdale
RecruitingObservational study
Ages 18 and older · All sexes · Updated Feb 18, 2026 · NCT04202341From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.